CD19 and common variable immunodeficiency: Notably, IgG responses were induced in all CVID patients after condition II stimulation when calculated for CD19+ B-cells (Figure 3A) and in 12/13 CVID patients for CS PBs (Figure 3C), which are the primary source of ASCs.